Aging and Brain Function
Posted by katie at 3:51 pm
Q&A
Aging and Brain Function
A conversation with Randy Buckner.
http://www.hhmi.org/bulletin/pdf/winter2005/Q&A.pdf
Randy Buckner studies factors that contribute to cognitive loss in aging.
hhmi bulletin | winter 2005 13
HHMI investigator Randy L. Buckner is always surprised when his studies on aging and brain function get media attention. He shouldn’t be. Baby boomers are pushing 60, approaching the stage of life when their risk of Alzheimer’s disease doubles every 5 years. So when Buckner and his team at Washington University in St. Louis talk about how the brain compensates for cognitive loss, people listen. According to his two most recent papers, changes in the brain that occur with normal aging and that can impede high-level thinking are separate from those of Alzheimer’s disease.
Why do you argue that Alzheimer’s disease is not accelerated aging?
Buckner: Data from structural studies, functional studies, even research on rare genetic mutations all strongly support a separation hypothesis—that aging and Alzheimer’s disease affect different regions of the brain. In normal aging, sections of the frontal lobe shrink, but in Alzheimer’s the main area affected is the medial temporal lobe, which contains the hippocampus. The effects are different too. The cognitive loss from normal aging involves executive function—our ability to plan and do complex tasks. Simple remembering is usually retained. But patients with Alzheimer’s disease experience profound, often rapid, memory loss. They forget recently learned information, for example, and ask the same questions over and over. Exciting research by William E. Klunk at the University of Pittsburgh School of Medicine, using a new compound with PET [position emission tomography] to image amyloid plaques [fibrous-protein deposits characteristic of Alzheimer’s] in the brain, lets us see rather directly what we think is the pathology in Alzheimer’s. Helped by our Washington University colleague Mark Mintun, we’ve been integrating amyloid imaging with structural changes and can see the progression of atrophy in the brain.
The world is focused on changes in Alzheimer’s. Meanwhile, what do we know about the physical changes of normal aging and their effects on cognitive function?
Buckner: Clinicians focus on Alzheimer’s disease because it is a big problem. Half of the people over age 85 have some form of dementia, most often Alzheimer’s. With nondemented aging, we see changes in white matter in anterior parts of the brain, and we take hypertension as at least a likely cause. We also see declines in the levels of neurotransmitters, such as dopamine, which have been linked to declines in executive function. I fit turned out that neurochemical modulations were closely related to cognitive changes in aging, I wouldn’t be surprised. There may be a shared mechanism or the changes may be distinct. We want to disentangle those influences and find out.
If hypertension is treated, does executive function improve?
Buckner: We don’t know, though there are hints that more hypertension means more damage. Arthur F. Kramer at the University of Illinois at Urbana-Champaign looked at elderly people with exceptional cardiovascular fitness, and they had what looked like healthier white matter than that of normal folks.
Why worry about these changes if they don’t lead to Alzheimer’s?
Buckner: Let’s assume for a moment that the field cures Alzheimer’s disease. Then we’ll be left with this other class of change, typically considered normal aging, that may suddenly become the focus, and we don’t have as much research on it. People in their 80s are slower than their younger selves, in every cognitive way. We are trying to understand these ubiquitous changes at a mechanistic level in order to get a better understanding of the complex constellation of factors that change with aging, and to see if some folks are more at risk. If we identify the mechanisms, maybe we can identify molecular cascades [the propagation of neurodegenerative changes] and slow them, or prevent them, so that an 80-year-old will act more like a 50-year-old.
Does cognitive training help?
Buckner: A lot of people are working on cognitive training, myself included, and our studies show that frontal resources are much more available given the right guidance. With the use of simple task helpers during memory exercises, older adults show increased activity in these frontal regions, and their memory performance improves. The challenge is in developing strategies that are generalizable. Individuals in studies can get better at a set of tasks they are trained on, but it doesn’t always work for other situations. The challenge of finding ways that help cognition and generalize to many situations is an important future topic for the field.
What made you focus your research on Alzheimer’s disease and the cognitive effects of aging?
Buckner: A lot of us choose to do research in areas that apply to our families. Longevity runs in my family, and several members have had Alzheimer’s disease. Two of my grandparents had Alzheimer’s in their early 80s.When I came to Washington University, there was strong community interest in aging, so I had wonderful colleagues and scientific accessibility as well as personal interest. —CORI VANCHIERI




